XILIO THERAPEUTICS INC
XLO·98422T100·US·Common Stock·Healthcare - Biotechnology-13D/G
XLO (XILIO THERAPEUTICS INC) is held by 14 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.7M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($1.1M), RENAISSANCE TECHNOLOGIES LLC ($614,586). Net institutional sentiment: Mixed.
14
Holders
$5.1M
Total Value
59% (17)
Consensus
10 buying - 7 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders Mar 30, 2026 · Activists May 15, 2026 · Congress none
ActivistOAORBIMED ADVISORS LLC10.0%May 15, 2026
ActivistSISirenia Capital Management LP9.9%May 15, 2026
Checking access…
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer